𝔖 Bobbio Scriptorium
✦   LIBER   ✦

In vitro and in vivo characterisation of a novel c-FLIP-targeted antisense phosphorothioate oligonucleotide

✍ Scribed by Andrew E. Logan; Timothy R. Wilson; Catherine Fenning; Rob Cummins; Elaine Kay; Patrick G. Johnston; Daniel B. Longley

Publisher
Springer
Year
2010
Tongue
English
Weight
564 KB
Volume
15
Category
Article
ISSN
1360-8185

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

In vitro and in vivo downregulation of M
In vitro and in vivo downregulation of MRP1 by antisense oligonucleotides: A potential role in neuroblastoma therapy
✍ Bryone J. Kuss; Margherita Corbo; Wen Min Lau; Dean A. Fennell; Nicholas M. Dean 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 148 KB

## Abstract The expression of MRP1 (multidrug resistance protein‐1) is associated with chemoresistance and poor prognosis in neuroblastoma. MRP1 antisense oligonucleotides were used in an __in vivo__ mouse‐human xenograft model of neuroblastoma to downregulate MRP1. The MRP1 ASO reduced protein lev

Evaluation of folate-PAMAM for the deliv
Evaluation of folate-PAMAM for the delivery of antisense oligonucleotides to rat C6 glioma cells in vitro and in vivo
✍ Chunsheng Kang; Xubo Yuan; Fei Li; Peiyu Pu; Shizhu Yu; Changhong Shen; Zhiyong 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 912 KB

## Abstract In the current study, we evaluated the efficiency of folate‐polyamidoamine dendrimers conjugates (FA‐PAMAM) for the __in situ__ delivery of therapeutic antisense oligonucleotides (ASODN) that could inhibit the growth of C6 glioma cells. Folic acid was coupled to the surface amino groups

In vivo comparison of 2′-O-methyl phosph
In vivo comparison of 2′-O-methyl phosphorothioate and morpholino antisense oligonucleotides for Duchenne muscular dystrophy exon skipping
✍ Hans A. Heemskerk; Christa L. de Winter; Sjef J. de Kimpe; Petra van Kuik-Romeij 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 409 KB

## Abstract ## Background Antisense‐mediated exon skipping is a putative treatment for Duchenne muscular dystrophy (DMD). Using antisense oligonucleotides (AONs), the disrupted DMD reading frame is restored, allowing generation of partially functional dystrophin and conversion of a severe Duchenne

In vitro evaluation of novel antisense o
In vitro evaluation of novel antisense oligonucleotides is predictive of in vivo exon skipping activity for Duchenne muscular dystrophy
✍ Qingsong Wang; HaiFang Yin; Patrizia Camelliti; Corinne Betts; Hong Moulton; Hyu 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 471 KB

## Abstract ## Background Targeted splice modulation of pre‐mRNA transcripts by antisense oligonucleotides (AOs) can correct the function of aberrant disease‐related genes. Duchenne muscular dystrophy (DMD) arises as a result of mutations that interrupt the open‐reading frame in the DMD gene encod